Further Support for Inhibition of Endogenous Insulin Secretion by Exogenous Insulin*

2009 ◽  
Vol 85 (01) ◽  
pp. 75-80 ◽  
Author(s):  
K.-P. Ratzmann ◽  
B. Schulz
2000 ◽  
Vol 52 (1) ◽  
pp. 87-92 ◽  
Author(s):  
Chul-Hee Kim ◽  
Joong Park ◽  
Young Shong ◽  
Sung Hong ◽  
Ghi Kim ◽  
...  

1988 ◽  
Vol 255 (6) ◽  
pp. R1035-R1040
Author(s):  
R. Hoo-Paris ◽  
M. L. Jourdan ◽  
L. C. Wang ◽  
R. Rajotte

In hypothermia, impairment of metabolic substrate mobilization and utilization may be a factor limiting survival. By use of a newly developed technique, substrate profiles and their regulation by insulin were examined in hypothermic rats (body temperature 19 degrees C) over 24 h. Plasma glucose concentrations increased to approximately 300 mg/dl during cooling and remained high throughout the period of hypothermia. Free fatty acid (FFA) concentration was not altered during cooling or during the first 10 h of hypothermia (approximately 700 mu eq/l) but progressively decreased thereafter, reaching 420 mu eq/l by 20 h. Plasma insulin decreased dramatically during cooling and remained very low (9 +/- 2 microU/ml) during the whole period of hypothermia, reflecting the suppression of insulin secretion by isolated islets at low temperatures. To test he hypothesis that suppression of endogenous insulin secretion may hamper glucose utilization and thus limit survival in hypothermia, exogenous insulin was administered. At doses of 0.1, 0.5, and 1 U/kg intravenously, insulin slowly decreased plasma glucose and FFA. However, at 0.1 and 1 U/kg intraperitoneally, insulin resulted in a dose-dependent decrease in survival time in the hypothermic rat. It is possible that the antilipolytic effect of insulin may have outweighed any beneficial effect of improving glucose utilization in hypothermia.


2015 ◽  
Vol 37 (8) ◽  
pp. e59
Author(s):  
E.R. Salis ◽  
M.K. Soelbeck ◽  
D.M. Reith ◽  
B.J. Wheeler ◽  
R.S. Broadbent ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document